Search

Issue
Title
Authors
Principles of treatment of different forms of alcoholic liver disease: A review
Raikhelson K.L., Kondrashina E.A., Pazenko E.V.
Assessment of the possible impact of hepatitis viruses on the development and course of autoimmune liver diseases
Sbikina E.S., Vinnitskaya E.V., Batskikh S.N., Sandler Y.G., Saliev K.G., Khaimenova T.Y., Bordin D.S.
Prognostic factors in patients with hematological malignancies and concomitant chronic hepatitis C
Nozhkin M.S., Lioznov D.A., Antonova T.V., Gorchakova O.V., Goldstein E.M., Popova M.O., Shneyder T.V.
Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis
Bogomolov P.O., Ivashkin V.T., Bueverov A.O., Maev I.V., Sagalova O.I., Sleptsova S.S., Yushuk N.D., Gusev D.A., Zhdanov K.V., Chulanov V.P.
A clinical case of three times treatment of hepatitis C with repeated infection in HIV-positive patient. Case Report
Pokrovskaya A.V., Popova A.A.
Mixed infection: viral hepatitis A and hemorrhagic fever with renal syndrome. Case report
Bondarenko A.L., Protasov A.V., Rokhin E.A., Slobozhaninova Y.P.
Treatment of toxic hepatitis in COVID-19 patients
Maev I.V., Shaburov R.I., Pavlov A.I., Molodova A.I., Karakozov A.G., Kazakov S.P., Lebedeva E.G., Ivolgin A.F., Eremin M.N., Levchenko O.B.
Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review
Gridneva G.I., Belov B.S., Aronova E.S.
Nonalcoholic fatty liver disease: What do we know and what will we have to learn?
Volkova N.I., Porksheyan M.I.
Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy
Dudina K.R., Belyy P.A., Maev I.V., Klimova E.A., Shutko S.A., Znoyko O.O., Yuschuk N.D.
Drug-induced liver injury: diagnosis of exclusion
Maev I.V., Polunina T.E.
The relevance and prospects of introducing a uniform federal register of patients with viral hepatitis B and C in Russia
Pimenov N.N., Vdovin A.V., Komarova S.V., Mamonova N.A., Chulanov V.P., Pokrovskiĭ V.I.
Comparative evaluation of the effectiveness of narlaprevir in the composition of interferon and interferon-free treatment regimens for patients with chronic hepatitis C
Grushko I.P., Romanova E.B., Tverdokhlebova T.I., Gapon M.N., Vodyanitskaya S.Y.
COVID-19 as a trigger of autoimmune hepatitis. Case report
Volchkova E.A., Legkova K.S., Topchy T.B.
A medicinal liver injury with an immunomodulatory drug of natural origin. Case report
Reznik E.V., Yudin D.V., Gudilova Y.Y., Baikova I.E., Karmanova S.E., Nikitin I.G.
The clinical and hemostasiological features of chronic hepatitides of different genesis
Bilalova A.R., Makashova V.V., Astrina O.S., Aleshina N.I., Florianu A.I.
A variety of extrahepatic manifestations of chronic viral hepatitis B and C: basic treatment principles
Baĭkova T.A., Lopatkina T.N.
Lymphocyte subpopulations, levels of interferon, and expression of their receptors in patients with chronic hepatitis B and C: Correlation with the species of viruses and the degree of liver fibrosis
Kalyuzhin O.V., Ponezheva Z.B., Semenova I.V., Khokhlova O.N., Serebrovskaya L.V., Guseva T.S., Parshina O.V., Maleev V.V.
Сlinical, immunological and morphological features in different types of autoimmune hepatitis
Sandler Y.G., Saliev K.G., Backih S.N., Khomeriki S.G., Khaymenova T.Y., Dorofeev A.S., Sbikina E.S., Vinnitskaya E.V.
Role of transforming growth factor-beta in the development of some liver diseases
Raĭkhel'son K.L., Karev V.E., Marchenko N.V., Semenov N.V., Pal'gova L.K., Baranovskiĭ A.I.
Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C
Maev I.V., Kuznetsova E.I., Andreev D.N., Dicheva D.T.
Possibilities of therapeutic correction of hyperammonemia and minimal hepatic encephalopathy in patients with chronic hepatitis C at the pre-cirrhotic stage
Buyeverov A.O., Bogomolov P.O., Mayev I.V., Matsievich M.V., Uvarova O.V.
Variety of lung involvement in autoimmune liver diseases
Akulkina L.A., Brovko M.Y., Sholomova V.I., Rozina T.P., Yanakayeva A.S., Frantsuzevich L.Y., Lebedeva M.V., Fomin V.V.
The efficiency and safety of anti-Helicobacter pylori therapy in patients with concomitant chronic hepatitis C
Andreev D.N., Maev I.V., Kucheryavyi Y.A., Dicheva D.T., Partsvania-vinogradova E.V.
Entecavir in the treatment of chronic hepatitis B: multicenter randomized trials and real clinical practice
Abdurakhmanov D.T., Otrashevskaia A.V.
Significance of allelic variants of interleukin-28B gene in chronic hepatitis C
Tikhonova N.I., Burnevich É.Z., Krasnova T.N.
A case of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with diffuse large B-cell lymphoma and chronic hepatitis B virus infection
Melikian A.L., Kovrigina A.M., Giliazitdinova E.A., Gitis M.K.
B-cell lymphoma in a woman with chronic hepatitis C and mixed cryoglobulinemia of type 2
Ignatova T.M., Milovanova S.Y., Chernova O.A., Bayzhanova Z.Z., Ignatova T.M., Milovanova S.Y., Chernova O.A., Baizhanova Z.Z.
The course and treatment of chronic hepatitis B in HIV-infected patients
Maksimov S.L., Tsarenko S.P., Kravchenko A.V., Yushchuk N.D., Maksimov S.L., Tsarenko S.P., Kravchenko A.V., Yushchuk N.D.
Effects of interferon therapy onfunctional activity of platelets in chronic viral hepatitis andcirrhosis of the liver
Yagoda A.V., Koroi P.V.
Autoimmune manifestations in acute viralhepatitides
Volchkova Y.V., Allenov M.N., Umbetova К.Т., Ivanovo I.V., Pak S.G.
Treatment of chronic viral hepatitis C with direct acting antiviral agent: review
Malov V.A., Ubeeva E.A., Ubeeva I.P., Nikolaev S.M., Umbetova K.T.
Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B
Ibragimov E.K., Abdurakhmanov D.T., Rozina T.P., Nikulkina E.N., Tanaschuk E.L., Odintsov A.V., Panevkina S.V., Moiseev S.V.
HCV-associated mixed cryoglobulinemia and b-cell non-Hodgkin's lymphoma - pathogenetically related problems
Milovanova S.Y., Lysenko (Kozlovskaya) L.V., Milovanova L.Y., Mrykhin N.N., Russkih A.V., Muchin N.A.
Possibilities of using cepeginterferon alpha-2b in double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alpha-2b, and ribavirin) antiviral therapy regimens for chronic hepatitis C. A review of clinical trials and experience of everyday clinical practice
Znoyko O.O., Klimova E.A., Maevskaya M.V., Shuldyakov А.A., Linkova Y.N., Morozova M.A.
Resistance to protease inhibitors and efficiency of antiviral therapy in patients with chronic hepatitis C
Batskikh S.N., Karandashova I.V., Neverov A.D., Chulanov V.P.
Pulmonary vasculitis as a clinical mask of HCV infection: Efficiency of interferon-free antiviral therapy
Stel'makh V.V., Kozlov V.K., Sukhanov D.S., Skipskiĭ I.M.
Triple therapy for chronic hepatitis C: Practical Aspects
Bakulin I.G., Kiseleva A.V.
Long-term entecavir efficacy retention in the treatment of chronic hepatitis B with an outcome to hepatic cirrhosis caused by its resistant virus strain
Znoĭko O.O., Dudina K.R., Safiullina N.K., Karandashova I.V., Chulanov V.P.
Clinical significance of intravital morphological investigation of the liver
Khomeriki S.G., Yakimchuk G.N., Golovanova E.V., Homeriki S.G., Yakimchuk G.N., Golovanova E.V.
Metabolic syndrome and insulin resistance in patients with chronic hepatitis C
Bayzhanova Z.Z., Ignatova T.M., Nekrasova T.P., Baizhanova Z.Z., Ignatova T.M., Nekrasova T.P.
HBeAg-negative chronic hepatitis
Ibragimova M.M., Krel P.E., Abdurakhmanov D.T.
Some aspects of laboratory diagnosis of viral hepatitis В and С
Iliyina E.N., Govorun V.М., Ivanikov I.О.
Activity an enzyme 5`-nucleotidase in patients with chronic hepatitis C
Galeeva N.V., Valeeva I.K.
Prediction of features of the course of chronic hepatitis C using Bayesian networks
Samokhodskaya L.M., Starostina E.E., Sulimov A.V., Krasnova T.N., Rosina T.P., Avdeev V.G., Savkin I.A., Sulimov V.B., Mukhin N.A., Tkachuk V.A., Sadovnichii V.A.
Important problems in the diagnosis and treatment of autoimmune hepatitis (based on the Russian consensus 2017)
Vinnitskaya E.V., Sandler Y.G., Bakulin I.G., Parfenov A.I., Ilchenko L.Y., Nikitin I.G., Bueverov A.O., Lopatkina T.N., Ignatova T.M., Syutkin V.Y., Raikhelson K.L., Khomeriki S.G., Gudkova R.B.
Role of polymorphic markers for the genes of hemostasis and platelet receptors in liver fibrosis progression in patients with chronic hepatitis C
Starostina E.E., Samokhodskaya L.M., Rozina T.P., Krasnova T.N., Yarovaya E.B., Mukhin N.A.
Topical problems of antiviral therapy for chronic hepatitis C
Bakulin I.G.
Endothelial dysfunction markers (VCAM-1, vWF) in chronic hepatitis C
Antonova T.V., Romanova M.A., Lymar' I.V.
A histological response to antiviral therapy for chronic hepatitis C in patients who failed to achieve a sustained virological response
Riumin A.M., Korochkina O.V.
1 - 50 of 109 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies